Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B-Cell Lineage Envelope Design |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2013-09-17 |
| Study Made Public: | 2015-06-29 |
Title
Neutralization of SHIVs by monoclonal antibodies isolated from RV144 PBMCs and produced as recombinant mAbs
Description
CAVD 426 is an antibody screening study to isolate and characterize monoclonal antibodies from RV144, RV305, and RV306 human clinical trial subjects.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.